Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma
Abstract Clear cell renal cell carcinoma (ccRCC) is one of the most common subtypes of renal cancer, with 30% of patients presenting with systemic disease at diagnosis. This aggressiveness is a consequence of the activation of epithelial–mesenchymal transition (EMT) caused by many different inducers...
Main Authors: | Martyna Parol‐Kulczyk, Justyna Durślewicz, Laura Blonkowska, Radosław Wujec, Arkadiusz Gzil, Daria Piątkowska, Joanna Ligmanowska, Dariusz Grzanka |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-03-01
|
Series: | The Journal of Pathology: Clinical Research |
Subjects: | |
Online Access: | https://doi.org/10.1002/2056-4538.12365 |
Similar Items
-
Targeting the Deterministic Evolutionary Trajectories of Clear Cell Renal Cell Carcinoma
by: Adam Kowalewski, et al.
Published: (2020-11-01) -
Low Expression of MATR3 Is Associated with Poor Survival in Clear Cell Renal Cell Carcinoma
by: Justyna Durślewicz, et al.
Published: (2023-01-01) -
Metabolic reprogramming of clear cell renal cell carcinoma
by: Haiyan Zhu, et al.
Published: (2023-06-01) -
The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?
by: Alessandra Cinque, et al.
Published: (2022-10-01) -
MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma
by: Longxiyu Meng, et al.
Published: (2023-12-01)